Evidence map›Paper›PMID 41149419›Full record

ArticleGels (Basel, Switzerland)2025

The Potential of Dosimetry and the Visualization of Microbeam Arrays in NIPAM Gel at the PETRA III Synchrotron.

Thomas Breslin, Malin Kügele, Vincent de Rover, Stefan Fiedler, Tobias Lindner, Johannes Klingenberg, Guilherme Abreu Faria, Bernd Frerker, Frank Nuesken, Sofie Ceberg and 4 more

Abstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Thomas BreslinDepartment of Oncology, Clinical Sciences, Lund University, 22185 Lund, Sweden.ORCID 0000-0001-6685-148X
Malin KügeleDepartment of Radiooncology, Rostock University Medical Center, 18059 Rostock, Germany.ORCID 0000-0002-7213-111X
Vincent de RoverCentre of Medical Radiation Physics, University of Wollongong, Wollongong 2522, Australia.
Stefan FiedlerEuropean Molecular Biology Laboratory (EMBL), Hamburg Outstation, 22607 Hamburg, Germany.ORCID 0000-0002-3623-3311
Tobias LindnerCore Facility Multimodale Kleintierbildgebung, Rostock University Medical Center, 18055 Rostock, Germany.ORCID 0000-0001-7826-3132
Johannes KlingenbergHelmholtz-Zentrum Hereon, 21502 Hamburg, Germany.
Guilherme Abreu FariaHelmholtz-Zentrum Hereon, 21502 Hamburg, Germany.
Bernd FrerkerDepartment of Radiooncology, Rostock University Medical Center, 18059 Rostock, Germany.ORCID 0009-0009-1436-6592
Frank NueskenDepartment of Radiooncology, Rostock University Medical Center, 18059 Rostock, Germany.
Sofie CebergMedical Radiation Physics, Clinical Sciences, Lund University, 22185 Lund, Sweden.
Crister CebergMedical Radiation Physics, Clinical Sciences, Lund University, 22185 Lund, Sweden.
Michael LerchCentre of Medical Radiation Physics, University of Wollongong, Wollongong 2522, Australia.ORCID 0000-0002-2406-9972
Guido HildebrandtDepartment of Radiooncology, Rostock University Medical Center, 18059 Rostock, Germany.ORCID 0000-0002-0498-2692
Elisabeth SchültkeDepartment of Radiooncology, Rostock University Medical Center, 18059 Rostock, Germany.ORCID 0000-0002-1273-0065

Funding

Australian Government Research Training Program AwardAustralian Institute of Nuclear Science and Engineering (ANSE) Postgraduate Research Award.Deutsche Forschungsgemeinschaft SCHU 2589/7-3Fru Berta Kamprads stiftelse FBKS-2023-43Swedish Foundation for International Cooperation in Research and Higher Education MG2020-8865
6 · The paper itself

Abstract

Spatially fractionated radiotherapy (SFRT) is emerging as a powerful tool in cancer therapy for patients who are ineligible for treatment with clinically established irradiation techniques. Microbeam radiotherapy (MRT) is characterized by spatial dose fractionation in the micrometre range. This presents challenges in both treatment planning and dosimetry. While a dosimetry system with a spatial resolution of 10 µm and an option for real-time readout already exists, this system can only record dose in a very small volume. Thus, we are exploring dosimetry in an N-isopropylacrylamide (NIPAM) gel as an option for 3D dose visualization and, potentially, also three-dimensional dosimetry in larger volumes. In the current study, we have recorded the geometric patterns of single- and multiport irradiation with microbeam arrays in NIPAM gel. Data for 3D dose distribution was acquired in a 7T small animal MRI scanner. We found that the resolution of the gel is well suited for a detailed 3D visualization of microbeam patterns even in complex multiport geometries, similar to that of radiochromic film, which is well established for recording 2D dose distribution in MRT. The results suggest that a dose-response calibration is required for reliable quantitative dosimetry.

Indexed as

3D visualizationbeam geometrydosimetrymicrobeam radiotherapy (MRT)MRINIPAM gelspatially fractionated radiotherapy

Identifiers

PMID41149419
PMCPMC12563062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.